miR-195-5p Targets CDK1 To Regulate New DNA Synthesis and Inhibit the Proliferation of Hepatocellular Carcinoma Cells
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-195-5p Targets CDK1 To Regulate New DNA Synthesis and Inhibit the Proliferation of Hepatocellular Carcinoma Cells
Authors
Keywords
-
Journal
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-01-06
DOI
10.1007/s12010-022-04279-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LINC00346 Acts as a Competing Endogenous RNA Regulating Development of Hepatocellular Carcinoma via Modulating CDK1/CCNB1 Axis
- (2020) Jinglan Jin et al. Frontiers in Bioengineering and Biotechnology
- Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
- (2020) Federico Piñero et al. Cells
- High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma
- (2019) Junjie Piao et al. GENE
- Hepatocellular carcinoma in the era of immunotherapy
- (2018) Hao-Wen Sim et al. CURRENT PROBLEMS IN CANCER
- Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma
- (2018) Chuan Xing Wu et al. Theranostics
- Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer
- (2016) Wookyeom Yang et al. Oncotarget
- MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma
- (2015) HUI XU et al. ONCOLOGY REPORTS
- High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients
- (2015) Wen-Wei Sung et al. BMC CANCER
- Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients
- (2013) J M Willder et al. BRITISH JOURNAL OF CANCER
- MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion
- (2012) Qian-Qian Zhang et al. NEURO-ONCOLOGY
- Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer
- (2011) D. Li et al. CLINICAL CANCER RESEARCH
- The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma
- (2011) Deniz M Özata et al. ENDOCRINE-RELATED CANCER
- Inhibitory Phosphorylation of Cyclin-Dependent Kinase 1 as a Compensatory Mechanism for Mitosis Exit
- (2011) J. P. H. Chow et al. MOLECULAR AND CELLULAR BIOLOGY
- Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition
- (2011) Neil Johnson et al. NATURE MEDICINE
- Active and passive tumor targeting of a novel poorly soluble cyclin dependent kinase inhibitor, JNJ-7706621
- (2010) Fabienne Danhier et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cyclin-dependent kinase 1 plays a critical role in DNA replication control during rat liver regeneration
- (2009) Delphine Garnier et al. HEPATOLOGY
- MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells
- (2009) Teng Xu et al. HEPATOLOGY
- Cdk1 Participates in BRCA1-Dependent S Phase Checkpoint Control in Response to DNA Damage
- (2009) Neil Johnson et al. MOLECULAR CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now